IsoRay, Inc. (NASDAQ:ISR) traded up 2.4% during mid-day trading on Thursday . The company traded as high as $0.42 and last traded at $0.42, 300 shares were traded during trading. A decline of 100% from the average session volume of 157,692 shares. The stock had previously closed at $0.41.
The business’s 50 day simple moving average is $0.42.
IsoRay (NASDAQ:ISR) last issued its quarterly earnings results on Thursday, May 9th. The company reported ($0.02) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.02). The firm had revenue of $1.92 million for the quarter, compared to the consensus estimate of $1.92 million.
IsoRay, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma.
Featured Story: How to use beta for portfolio diversification
Receive News & Ratings for IsoRay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IsoRay and related companies with MarketBeat.com's FREE daily email newsletter.